Direct Stenting with TAXUS Stents Seems to be as Safe and Effective as with Predilatation

Author： Silber Sigmund   Hamburger Jaap   Grube Eberhard   Pfisterer Matthias   Belardi Jorge   Webb John   Zmudka Krzysztof   Nienaber Christoph   Hauptman Karl   Rutsch Wolfgang   Dawkins Keith   Drzewiecki Janusz   Koglin Jörg   Colombo Antonio  

Publisher： Springer Publishing Company

ISSN： 0340-9937

Source： Herz, Vol.29, Iss.2, 2004-03, pp. : 171-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes

By IJsselmuiden AJJ   Tangelder GJ   Cotton JM   Vaijifdar B   Kiemeneij F   Slagboom T   Wieken R v/d   Serruys PW   Laarman GJ  

International Journal of Cardiovascular Interventions, Vol. 5, Iss. 3, 2003-07 ,pp. : 143-150

Informa Healthcare

Access to resources Recommend Favorite

Impact of operator volume on overall major adverse cardiac events following direct coronary stent implantation versus stenting after predilatation

By IJsselmuiden Sander  

International Journal of Cardiovascular Interventions, Vol. 6, Iss. 1, 2004-03 ,pp. : 5-12

Informa Healthcare

Access to resources Recommend Favorite

Direct stenting with the Bx VELOCITY™ balloon-expandable stent mounted on the Raptor® rapid exchange delivery system versus predilatation in a European randomized Trial: the VELVET trial

By Serruys Patrick W   IJsselmuiden Sander   Hout Ben van   Vermeersch Paul   Bramucci Ezio   Legrand Victor   Pieper Michael   Antoniucci David   Gomes Ricardo Seabra   Macaya Carlos   Boekstegers Peter   Lindeboom Wietze  

International Journal of Cardiovascular Interventions, Vol. 5, Iss. 1, 2003-01 ,pp. : 17-26

Informa Healthcare

Access to resources Recommend Favorite

Intra-Graft Abciximab and Verapamil Combined with Direct Stenting is a Safe and Effective Strategy to Prevent Slow-flow and No-Reflow Phenomenon in Saphenous Vein Graft Lesions not Associated with Thrombus

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 152-159

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Tissue Plasminogen Activator Thrombolysis in Patients without Major Arterial Occlusion Seems to Be Safe and Effective

By  

European Neurology, Vol. 64, Iss. 5, 2010-10 ,pp. : 258-264

Karger

Access to resources Recommend Favorite